Teva CEO says manufacturing cuts will keep coming even after $3B reduction achieved

The way Teva CEO Kåre Schultz figures it, manufacturing is the cost-cutting gift that keeps on giving. After the company completes the $3 billion cost reduction effort, it can still look to manufacturing efficiencies to help it move up its margin.